Myles Minter

Stories

Lilly and Hims move branded obesity drugs onto the telehealth platform

Covering Alnylam

A patient on Hims & Hers can now get a prescription for Eli Lilly's obesity drugs and have them shipped to their door without leaving the app. Before Nov. 6, Lilly's Zepbound and Foundayo were only reachable through Lilly's own cash-pay site, LillyDirect.

Updated 2 days ago

Merck KGaA to buy Silence Therapeutics for $1.3 billion

Money Moves

Covered Silence Therapeutics

Merck KGaA agreed on October 19 to buy Silence Therapeutics for $1.3 billion in cash, paying $20 per American Depositary Share. That is 130% above Silence's closing price on October 16.

Updated Oct 20

Notable Quotes

"Growth rate visibility is murky at best."

from Lilly and Hims move branded obesity drugs onto the telehealth platform · Updated 2 days ago

"This deal takes the execution risk off the table in an increasingly competitive space and delivers near-term shareholder value from what appears to be a competitive bid process."

from Merck KGaA to buy Silence Therapeutics for $1.3 billion · Updated Oct 20